Physician profile
Michael Camp
NPI 1427056365
$3,844.38
in general payments reported to CMS, 2019-2025
18 companies · $1,105 in 2025
The $1,105 reported for 2025 was more than what 92% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $364 · 2020: $144 · 2021: $494 · 2022: $322 · 2023: $697 · 2024: $718 · 2025: $1,105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,521.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,520.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $959.27 | 2022-2025 | Lumigan, Alphagan P, Vuity |
| Bausch & Lomb Americas INC. | $435.61 | 2024-2025 | Miebo, Xiidra, Biotrue One Day |
| Allergan, INC. | $414.29 | 2019-2022 | |
| Alcon Vision LLC | $358.31 | 2022-2025 | Precision7, Clareon, Tryptyr |
| Sun Pharmaceutical Industries INC. | $274.68 | 2019-2023 | Cequa |
| Johnson & Johnson Surgical Vision, INC. | $256.30 | 2023-2024 | Tecnis Iol |
| Sight Sciences, INC. | $204.89 | 2021-2025 | Tearcare System |
| Tarsus Pharmaceuticals, INC. | $185.28 | 2024-2025 | Xdemvy |
| Aerie Pharmaceuticals, INC. | $163.60 | 2019-2021 | |
| Horizon Therapeutics Plc | $122.66 | 2021-2023 | Tepezza |
| Biotissue Holdings INC. | $116.49 | 2023-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $103.87 | 2019-2020 | |
| Rxsight INC | $87.92 | 2021 | |
| Novartis Pharmaceuticals Corporation | $68.27 | 2020-2023 | |
| Glaukos Corporation | $33.67 | 2025 | Idosetr |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $27.69 | 2025 | Izervay |
| Lensar, INC. | $17.59 | 2025 | Lensar Laser System |
| Notal Vision, INC. | $13.99 | 2024 | Foresee Home |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Camp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.